Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edge Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Edge Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Edge Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is EDGE. The reporting company's CIK number is 1472091.
The total value of stock buying since 2005 is $15,107,640.
The total value of stock sales since 2005 is $658,654.
The total value of stock option exercises since 2005 is $127,950.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-04||Leuthner Brian A (President and CEO)||Sale||2,500||11.14||27,850|
|2017-10-03||Leuthner Brian A (President and CEO)||Sale||2,500||10.93||27,325|
|2017-10-02||Leuthner Brian A (President and CEO)||Sale||2,500||10.81||27,025|
|2017-09-06||Leuthner Brian A (President and CEO)||Sale||2,500||10.31||25,775|
|2017-09-05||Leuthner Brian A (President and CEO)||Sale||2,500||9.94||24,850|
|2017-09-01||Leuthner Brian A (President and CEO)||Sale||2,500||10.37||25,924|
|2017-08-29||Marchio Albert N Ii (Chief Accounting & Adm Officer)||Sale||2,500||10.42||26,050|
|2017-08-23||Marchio Albert N Ii (Chief Accounting & Adm Officer)||Sale||1,000||10.39||10,390|
|2017-08-03||Leuthner Brian A (President and CEO)||Sale||2,500||10.40||26,000|
|2017-08-02||Leuthner Brian A (President and CEO)||Sale||2,500||10.53||26,325|
|2017-08-01||Leuthner Brian A (President and CEO)||Sale||2,500||10.65||26,625|
|2017-07-06||Leuthner Brian A (President and CEO)||Sale||2,500||10.08||25,200|
|2017-07-05||Leuthner Brian A (President and CEO)||Sale||2,500||10.21||25,525|
|2017-07-03||Leuthner Brian A (President and CEO)||Sale||2,500||10.27||25,675|
|2017-04-26||Leuthner Brian A (President and CEO)||Sale||100||11.10||1,110|
|2017-03-06||Loughlin James J (Director)||Buy||3,000||9.24||27,720|
|2017-02-07||Leuthner Brian A (President and CEO)||Sale||1,500||9.52||14,280|
|2017-02-06||Leuthner Brian A (President and CEO)||Sale||1,500||9.52||14,280|
|2017-02-03||Leuthner Brian A (President and CEO)||Sale||1,500||9.69||14,535|
|2017-02-02||Leuthner Brian A (President and CEO)||Sale||1,500||9.61||14,415|
|2017-02-01||Leuthner Brian A (President and CEO)||Sale||1,500||9.38||14,070|
|2017-01-23||Macdonald R. Loch (Chief Scientific Officer)||Option Ex||25,000||2.04||51,000|
|2016-12-01||Leuthner Brian A (President and CEO)||Sale||7,500||11.60||87,000|
|2016-10-03||Leuthner Brian A (President and CEO)||Sale||7,500||10.25||76,845|
|2016-08-08||Middlekauff W Bradford (Senior VP, GC and Secretary)||Buy||143||9.43||1,348|
|2016-08-05||Middlekauff W Bradford (Senior VP, GC and Secretary)||Buy||9,857||9.48||93,444|
|2016-08-01||Leuthner Brian A (President and CEO)||Sale||7,500||9.54||71,580|
|2016-06-16||Vaish Renu (V.P., Global Reg. Affairs)||Option Ex||10,000||5.13||51,300|
|2016-03-11||Loughlin James J (Director)||Buy||3,000||7.62||22,875|
|2015-10-06||Vaish Renu (V.P., Global Reg. Affairs)||Buy||350||11.00||3,850|
|2015-10-06||Faleck Herbert J (Chief Medical Officer)||Buy||500||11.00||5,500|
|2015-10-06||Einhorn Andrew J. (Chief Financial Officer)||Buy||45,000||11.00||495,000|
|2015-10-06||Spiegel Robert J.||Buy||3,000||11.00||33,000|
|2015-10-06||Hove Anders D||Buy||450,000||11.00||4,950,000|
|2015-10-06||Loughlin James J||Buy||7,000||11.00||77,000|
|2015-10-06||Barer Sol J||Buy||45,000||11.00||495,000|
|2015-10-06||Marchio Albert N Ii (Chief Acct. & Op., Asst. Sec.)||Buy||100||11.00||1,100|
Insider trading activities including stock purchases, stock sales, and option exercises of EDGE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Edge Therapeutics, Inc. (symbol EDGE, CIK number 1472091) see the Securities and Exchange Commission (SEC) website.